Entero Healthcare Solutions Limited — Updates, 19-03-2025: Press Release

Entero Healthcare Solutions Limited has launched its 'HealthEdge' programme aimed at empowering retail chemists through digital transformation. This initiative is bolstered by the acquisition of the Aayu Chemist app and Medcords platform from Medcords Healthcare Solutions. The company, currently engaging with over 86,000 retail chemists, is focused on enhancing operational efficiency and profitability through innovative tools.

Key features of the 'HealthEdge' programme include advanced inventory management, transparent expiry management, exclusive access to high-margin deals, and financial support options. Additionally, the programme fosters customer retention with tools for reminders and loyalty programs, as well as access to healthcare services like doctor consultations.

Entero has reported strong performance in Q3FY25 with a 37% increase in revenue and a remarkable 322% growth in profit after tax (PAT) compared to the previous year. This strategic move positions Entero favorably for future growth, emphasizing the integration of technology in healthcare distribution. Investors should monitor the rollout of this initiative, as it may unlock significant value and reinforce Entero's market position.